• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耳念珠菌菌血症在重症监护病房的流行情况—一项评估流行病学、风险因素和预后的前瞻性观察研究。

Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome.

机构信息

Critical Care & Emergency Medicine, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110060, India.

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

出版信息

J Crit Care. 2020 Jun;57:42-48. doi: 10.1016/j.jcrc.2020.01.004. Epub 2020 Jan 9.

DOI:10.1016/j.jcrc.2020.01.004
PMID:32062286
Abstract

PURPOSE

To determine the prevalence of Candida auris candidaemia in our ICU patients and its molecular epidemiology.

METHODS

A prospective observational study was conducted on candidaemia in our ICU patients over 18 months during 2016-2017. Demographics, underlying disease, risk factors, antifungal therapy and outcome were studied. Risk factors of C. auris and non-auris candidaemia were compared.

RESULTS

During the study period, among 108 candidaemia cases recorded, the incidence was 6.75/1000 ICU bed days. C. auris topped the list (n = 42, 39.9%), followed by C. tropicalis (34.3%), and C. parapsilosis (15.7%). On bivariate analysis prior antibiotic therapy, long central line days, mechanical ventilation and length of ICU stay were significant risk factors for C. auris candidaemia compared to non-auris candidaemia. Multivariate analysis showed underlying respiratory and neurological diseases as significantly associated with risk of C. auris candidaemia. Fluconazole, amphotericin B, and caspofungin resistance were noted in 97.0%, 93.7% and 3% of C. auris isolates respectively.

CONCLUSION

Longer duration of central line days, prior antibiotic use, mechanical ventilation and prolonged ICU stay were important risk factors associated with C. auris candidaemia along with underlying respiratory or neurological disease. The isolates are non-clonal in origin, but they belong to a single clade.

摘要

目的

确定我们 ICU 患者中念珠菌血症的流行情况及其分子流行病学。

方法

对 2016 年至 2017 年期间我们 ICU 患者的念珠菌血症进行了为期 18 个月的前瞻性观察研究。研究了人口统计学、基础疾病、危险因素、抗真菌治疗和结果。比较了 C. auris 和非 auris 念珠菌血症的危险因素。

结果

在研究期间,记录了 108 例念珠菌血症病例,发病率为 6.75/1000 ICU 床日。C. auris 位居榜首(n=42,39.9%),其次是 C. tropicalis(34.3%)和 C. parapsilosis(15.7%)。在单变量分析中,与非 auris 念珠菌血症相比,先前的抗生素治疗、中央导管留置时间长、机械通气和 ICU 住院时间长是 C. auris 念珠菌血症的显著危险因素。多变量分析显示,基础呼吸和神经系统疾病与 C. auris 念珠菌血症的风险显著相关。97.0%、93.7%和 3%的 C. auris 分离株分别对氟康唑、两性霉素 B 和卡泊芬净耐药。

结论

较长的中央导管留置时间、先前使用抗生素、机械通气和 ICU 住院时间延长以及基础呼吸或神经系统疾病是与 C. auris 念珠菌血症相关的重要危险因素。分离株起源是非克隆的,但它们属于单一的分支。

相似文献

1
Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome.耳念珠菌菌血症在重症监护病房的流行情况—一项评估流行病学、风险因素和预后的前瞻性观察研究。
J Crit Care. 2020 Jun;57:42-48. doi: 10.1016/j.jcrc.2020.01.004. Epub 2020 Jan 9.
2
Candida auris candidaemia in Indian ICUs: analysis of risk factors.印度重症监护病房中的耳念珠菌血症:危险因素分析
J Antimicrob Chemother. 2017 Jun 1;72(6):1794-1801. doi: 10.1093/jac/dkx034.
3
An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital.一家三级保健欧洲医院中,由于耳念珠菌导致的暴发感染,患者出现长时间定植和念珠菌血症。
Mycoses. 2018 Jul;61(7):498-505. doi: 10.1111/myc.12781. Epub 2018 Jun 8.
4
Increase in candidemia cases and emergence of fluconazole-resistant and isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023.COVID-19 大流行期间,希腊一家三级保健教学医院的念珠菌血症病例增加,以及氟康唑耐药和 分离株的出现,2020 年至 2023 年。
Euro Surveill. 2024 Jul;29(29). doi: 10.2807/1560-7917.ES.2024.29.29.2300661.
5
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
6
Antifungal resistance in patients with Candidaemia: a retrospective cohort study.念珠菌血症患者的抗真菌耐药性:一项回顾性队列研究。
BMC Infect Dis. 2020 Jan 17;20(1):55. doi: 10.1186/s12879-019-4710-z.
7
Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran.德黑兰儿医中心新生儿与小儿加护病房念珠菌血症的微生物流行病学。
Mycoses. 2018 Jan;61(1):22-29. doi: 10.1111/myc.12698. Epub 2017 Sep 22.
8
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.法国 ICU 获得性念珠菌血症:流行病学和时间趋势,2004-2013 年——来自 REA-RAISIN 网络的研究。
J Infect. 2017 Jul;75(1):59-67. doi: 10.1016/j.jinf.2017.03.011. Epub 2017 Mar 31.
9
Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: A single-centre retrospective 4-year analysis from Hungary.匈牙利单中心回顾性 4 年分析:念珠菌血症的流行病学、临床特征、结局和生物膜形成特性。
Mycoses. 2024 Apr;67(4):e13727. doi: 10.1111/myc.13727.
10
Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan.《巴基斯坦单中心研究:念珠菌感染的临床特征及影响预后的因素》。
BMC Infect Dis. 2019 May 6;19(1):384. doi: 10.1186/s12879-019-3999-y.

引用本文的文献

1
Consensus paper on by Türkiye EKMUD, ID-IRI, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, and TYBD.由土耳其共和国卫生部的土耳其EKMUD、ID-IRI、THSK、KLIMUD、TMC、TARD和TYBD发布的关于……的共识文件 (原文中“by”后面具体内容缺失)
Turk J Med Sci. 2025 Feb 2;55(4):1039-1062. doi: 10.55730/1300-0144.6059. eCollection 2025.
2
Innovative antifungal strategies to combat drug-resistant : recent advances and clinical implications.对抗耐药性的创新抗真菌策略:最新进展与临床意义
Front Cell Infect Microbiol. 2025 Jul 31;15:1641373. doi: 10.3389/fcimb.2025.1641373. eCollection 2025.
3
Comparative Clinical Characteristics and Outcomes of Candida (Candidozyma) auris vs. Non-C. auris Candidemia in Non-neutropenic Patients in South India.
印度南部非中性粒细胞减少患者中耳念珠菌(解脂念珠菌)与非耳念珠菌念珠菌血症的临床特征及结局比较
Mycopathologia. 2025 Aug 15;190(5):72. doi: 10.1007/s11046-025-00974-2.
4
Diagnostic Approaches for : A Comprehensive Review of Screening, Identification, and Susceptibility Testing.针对……的诊断方法:筛查、识别及药敏试验的全面综述
Microorganisms. 2025 Jun 24;13(7):1461. doi: 10.3390/microorganisms13071461.
5
Candida auris infections in ICU patients: risk factors, outcomes, and antifungal resistance patterns.重症监护病房患者的耳念珠菌感染:危险因素、结局及抗真菌耐药模式
Crit Care. 2025 Jul 28;29(1):332. doi: 10.1186/s13054-025-05544-y.
6
Risk Factors for Among Admitted Patients in Riyadh, Saudi Arabia (2020-2022).沙特阿拉伯利雅得住院患者中的危险因素(2020 - 2022年)
Infect Drug Resist. 2025 Jul 8;18:3369-3381. doi: 10.2147/IDR.S528127. eCollection 2025.
7
Patterns and Predictors of Candidemia with Multidrug-Resistant Bacterial Co-Infections: Results from the CANDI-MDR Study.多重耐药菌合并感染的念珠菌血症模式及预测因素:CANDI-MDR研究结果
J Fungi (Basel). 2025 May 25;11(6):407. doi: 10.3390/jof11060407.
8
Impact of on Critically Ill Patients: A Three-Year Observational Study in a Greek Intensive Care Unit.对危重症患者的影响:希腊一家重症监护病房的三年观察性研究。 (注:原文中“Impact of ”后面缺少具体内容,根据常见情况推测可能是某个因素对危重症患者的影响,所以在翻译时补充了“对”字,以使译文完整通顺)
Pathogens. 2025 Mar 28;14(4):328. doi: 10.3390/pathogens14040328.
9
The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin.新兴真菌病原体耳念珠菌诱导IFNγ以定殖于皮肤。
PLoS Pathog. 2025 Apr 28;21(4):e1013114. doi: 10.1371/journal.ppat.1013114. eCollection 2025 Apr.
10
Signaling pathways governing the pathobiological features and antifungal drug resistance of .调控……的病理生物学特征和抗真菌药物耐药性的信号通路 。(原文句子不完整,缺少关键内容)
mBio. 2025 May 14;16(5):e0247523. doi: 10.1128/mbio.02475-23. Epub 2025 Apr 3.